Exploration of the novel fluoroquinolones with high inhibitory effect against quinolone-resistant DNA gyrase of Salmonella Typhimurium
Microbiology Spectrum · 2023
DOI: 10.1128/spectrum.01330-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2023. Verfasst von Jirachaya Toyting und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Bioresources, Hokkaido University International Institute for Zoonosis Control , Sapporo, Japan. Hauptthemen laut MEDLINE: Quinolones. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development (AMED), MEXT | Japan Society for the Promotion of Science (JSPS).
Abstract (Originalsprache)
Quinolone-resistant nontyphoidal Salmonella , one of the prominent pathogens causing acute gastroenteritis, has become a public health concern globally. The World Health Organization has ranked fluoroquinolone-resistant Salmonella as a high-priority pathogen for researching and developing new antibiotics. WQ-3034 and WQ-3154 are relatively new synthetic fluoroquinolones with distinctive structures. WQ-3034 has 6-amino-3,5-difluoropyridine-2-yl at R 1 , 3-hydroxyazetidinyl at R 7 , and the addition of chlorine atom at R 8 . WQ-3154 has a similar basic pharmacophore to WQ-3034 except for the modification at R 8 with a methyl group. In this study, the inhibitory effect and DNA cleavage effect against wild-type (WT) and mutant Salmonella Typhimurium DNA gyrases of WQ-3034 and WQ-3154 were examined along with WQ-3810 and ciprofloxacin by measuring the drug concentration that inhibits half of the enzyme activity (IC 50 ) and the drug concentration that induces 25% of maximum DNA cleavage (CC 25 ). The minimum inhibitory concentration (MIC) of the compounds was assessed against Salmonella Typhimurium and Salmonella Enteritidis. Among four compounds, WQ-3034 demonstrated the highest inhibitory effect against both WT and mutant Salmonella Typhimurium DNA gyrases with amino acid substitution at codon 83 and/or 87, while ciprofloxacin showed the lowest inhibitory effect. Remarkably, WQ-3034 and WQ-3154 exhibited a significantly higher inhibitory effect than ciprofloxacin against Salmonella Typhimurium DNA gyrase with double amino acid substitution, Ser83Phe-Asp87Asn. Similarly, CC 25 of WQ-3034 against mutant Salmonella Typhimurium DNA gyrase was lower than ciprofloxacin. Notably, MICs of WQ-3034 and WQ-3154 were higher than ciprofloxacin. In conclusion, this study revealed that WQ-3034 and WQ-3154 could potentially be effective therapeutic agents against quinolone-resistant nontyphoidal Salmonella . IMPORTANCE Quinolone-resistant nontyphoidal Salmonella is a pressing public health concern, demanding the exploration of novel treatments. In this study, we focused on two innovative synthetic fluoroquinolones, WQ-3034 and WQ-3154. Our findings revealed that these new compounds demonstrate potent inhibitory effects, even against mutant strains that cause resistance to existing quinolones. Hence, WQ-3034 and WQ-3154 could potentially be effective therapeutic agents against quinolone-resistant Salmonella Typhimurium. Furthermore, the data obtained in this study will be baseline information for antimicrobial drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Bioresources, Hokkaido University International Institute for Zoonosis Control , Sapporo, Japan.
- Department of Microbiology, Faculty of Public Health, Mahidol University , Bangkok, Thailand.
- Biosafety and Environment Section, Research and Development Division, Philippine Carabao Center National Headquarters and Gene Pool Science City of Munoz , Munoz, Nueva Ecija, Philippines.
- Department of Veterinary Public Health, Faculty of Veterinary Medicine, Kasetsart University , Nakhon Pathom, Thailand.
- Department of Bacteriology II, National Institute of Infectious Diseases , Tokyo, Japan.
- Hokkaido University Institute for Vaccine Research & Development, Hokkaido University , Sapporo, Japan.
ORCID-Profile: Kentaro Koide, Hyun Kim, Jeewan Thapa, Yasuhiko Suzuki
Förderung
- Japan Agency for Medical Research and Development (AMED)
- MEXT | Japan Society for the Promotion of Science (JSPS)
Zitieren
APA
Toyting, J., Miura, N., Utrarachkij, F., Tanomsridachchai, W., Belotindos, L. P., Suwanthada, P., Kapalamula, T. F., Kongsoi, S., Koide, K., Kim, H., Thapa, J., Nakajima, C., & Suzuki, Y. (2023). Exploration of the novel fluoroquinolones with high inhibitory effect against quinolone-resistant DNA gyrase of Salmonella Typhimurium. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01330-23
Vancouver
Toyting J, Miura N, Utrarachkij F, Tanomsridachchai W, Belotindos LP, Suwanthada P, et al. Exploration of the novel fluoroquinolones with high inhibitory effect against quinolone-resistant DNA gyrase of Salmonella Typhimurium. Microbiology Spectrum. 2023. doi:10.1128/spectrum.01330-23
BibTeX
@article{Toyting2023,
author = {Toyting, Jirachaya and Miura, Nami and Utrarachkij, Fuangfa and Tanomsridachchai, Wimonrat and Belotindos, Lawrence P and Suwanthada, Pondpan and Kapalamula, Thoko Flav and Kongsoi, Siriporn and Koide, Kentaro and Kim, Hyun and Thapa, Jeewan and Nakajima, Chie and Suzuki, Yasuhiko},
title = {Exploration of the novel fluoroquinolones with high inhibitory effect against quinolone-resistant DNA gyrase of Salmonella Typhimurium},
journal = {Microbiology Spectrum},
year = {2023},
doi = {10.1128/spectrum.01330-23}
}
EUVIMED